APA (7th ed.) Citation

BG, T., H, L., SH, B., RI, F., WR, B., LM, R., . . . JW, F. (2016). Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601. British journal of haematology, 172(2), 208. https://doi.org/10.1111/bjh.13818

Chicago Style (17th ed.) Citation

BG, Till, et al. "Phase II Trial of R-CHOP Plus Bortezomib Induction Therapy Followed by Bortezomib Maintenance for Newly Diagnosed Mantle Cell Lymphoma: SWOG S0601." British Journal of Haematology 172, no. 2 (2016): 208. https://doi.org/10.1111/bjh.13818.

MLA (9th ed.) Citation

BG, Till, et al. "Phase II Trial of R-CHOP Plus Bortezomib Induction Therapy Followed by Bortezomib Maintenance for Newly Diagnosed Mantle Cell Lymphoma: SWOG S0601." British Journal of Haematology, vol. 172, no. 2, 2016, p. 208, https://doi.org/10.1111/bjh.13818.